Viral microRNAs responsible for causing AIDS-related cancer, new USC study shows

January 13, 2014

LOS ANGELES - For the first time, scientists and engineers have identified a critical cancer-causing component in the virus that causes Kaposi's sarcoma, the most common cancer among HIV-infected people. The discovery lays the foundation for developing drugs that prevent Kaposi's sarcoma and other related cancers.

"The mechanism behind the Kaposi's sarcoma-associated herpesvirus (KSHV) that causes healthy cells to become malignant is not well understood despite two decades of intensive studies," said S. J. Gao, Ph.D., professor of molecular microbiology and immunology at the Keck School of Medicine of the University of Southern California (USC) and principal investigator of the study. "This is the first time that a viral factor has been shown to be required for KSHV-induced malignant transformation. We have identified a mechanism by which these tiny viral molecules cause the cells to become malignant."

Distinguished by dark lesions on the skin, Kaposi's sarcoma most commonly develops in people who are infected with KSHV and also have compromised immune systems. Although many people infected with KSHV never show any symptoms, Kaposi's sarcoma is a persistent problem in areas where HIV infection is high and access to HIV therapy is limited. More than 90 percent of the population in some areas of Africa shows signs of KSHV infection, according to the American Cancer Society.

Gao and colleagues from the University of Texas at San Antonio (UTSA) and University of Texas Health Science Center at San Antonio studied KSHV using a rat stem cell model they developed in 2012. Until then, researchers had been unable to study the virus because most healthy cells, once infected with KSHV, died before turning into cancer cells.

In this study, which appears in the Dec. 26 edition of the peer-reviewed journal PLOS Pathogens, the team identifies a cluster of viral microRNA molecules that are necessary to transform healthy cells into cancerous ones. When this microRNA cluster was suppressed, the cells died after they were infected with KSHV. Flipping the switch and turning the cluster back "on," however, allowed the cells to stay alive and become malignant when infected with the virus.

Using advanced genomic methods, the researchers also found that the microRNAs target the IκBα protein and the NF-κB cellular pathway, both of which are associated with cancer development.

"Our results suggest that this cluster of KSHV microRNAs and their regulated NF-κB pathway may be potential targets for new therapeutics of KSHV-related cancers," said Gao, who is also a member of the USC Norris Comprehensive Cancer Center. "Several of the microRNAs appear to have redundant functions, so targeting their common pathways might be a more feasible approach. It would be interesting to test them in the KSHV-induced Kaposi's sarcoma model."
-end-
Yufei Huang, Ph.D., professor of electrical and computer engineering at UTSA, is the study's co-corresponding author. Other USC authors include researchers Ying Zhu, Ph.D., and Tiffany Jones, Ph.D. Their work was supported by the National Institutes of Health (grants CA096512, CA124332, and CA177377).

About Keck Medicine of USC

Keck Medicine of USC is the University of Southern California's medical enterprise, one of only two university-owned academic medical centers in the Los Angeles area. Encompassing academic, research and clinical entities, it consists of the Keck School of Medicine of USC, one of the top medical schools in Southern California; the renowned USC Norris Comprehensive Cancer Center, one of the first comprehensive cancer centers established in the United States; the USC Care faculty practice; the Keck Medical Center of USC, which includes two acute care hospitals: 411-bed Keck Hospital of USC and 60-bed USC Norris Cancer Hospital; and USC Verdugo Hills Hospital, a 158-bed community hospital. It also includes outpatient facilities in Beverly Hills, downtown Los Angeles, La Cañada Flintridge, Pasadena, and the USC University Park campus. Some Keck School of Medicine faculty also have practices throughout Los Angeles, Orange and Riverside counties.

University of Southern California - Health Sciences

Related Micrornas Articles from Brightsurf:

Breaking it down: How cells degrade unwanted micrornas
UT Southwestern researchers have discovered a mechanism that cells use to degrade microRNAs (miRNAs), genetic molecules that regulate the amounts of proteins in cells.

Is the COVID-19 virus pathogenic because it depletes specific host microRNAs?
Why is the COVID-19 virus deadly, while many other coronaviruses just cause colds?

Intracellular biopsy technique for fast microRNAs profiling in living cells
MicroRNAs (miRNAs) are gaining more attention in researches. To achieve fast and highly sensitive profiling of miRNAs, a research team from City University of Hong Kong (CityU) has developed a novel high-throughput intracellular biopsy technique that isolates targeted miRNAs from living cells within around 10 minutes by using diamond nanoneedles.

The function of new microRNAs are identified in Salmonella and Shigella infections
The research, published in Nature Microbiology, could help the search for more effective medicine and delves deeper into understanding the role of microRNAs in gene expression.

Protecting damaged hearts with microRNAs
Once the heart is formed, its muscle cells have very limited ability to regenerate.

A role for microRNAs in social behavior
Researchers have uncovered a microRNA cluster that regulates synaptic strength and is involved in the control of social behavior in mammals.

Genomic study finds a new role for microRNAs as predictors of Crohn's disease progression
A new study led by UNC School of Medicine researchers and has found that a set of biomolecules known as microRNAs, specifically microRNA-31 (miR-31), can help predict which patients with Crohn's disease are at higher risk for the development of severe problems that may require surgical removal of the large intestine.

Treating inflammatory bowel disorder by delivering microRNAs
Osaka University researchers efficiently delivered miRNAs to immune response cells in inflamed intestinal tracts using a super carbonate apatite (sCA), which had been shown to be highly effective in the delivery of nucleic acids to solid tumors, demonstrating the efficacy of sCA in the prevention and treatment of colitis in mice.

New screening approach reveals importance of microRNAs in papillomavirus life cycle
The discovery of microRNAs encoded by papillomaviruses supports the important role of these small molecules in persistent infection, according to a study published July 26 in the open-access journal PLOS Pathogens.

Magnetically applied MicroRNAs could one day help relieve constipation
Micro metal beads and magnets help deliver a biologic where it's needed to improve constipation or rectoanal incontinence in animal models of the disorders.

Read More: Micrornas News and Micrornas Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.